"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers."
"On January 3, 2012, Michael Toups resigned as a director of Lotus Pharmaceuticals, Inc. (the “Company”). Mr. Toups’s resignation was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices."
I think Mike's director role was convenient for LTUS given Mike's presence in China and knowledge of financial regs, already being CFO of LPH and another China small cap. Also, Mike didn't come on-board until long after LTUS's infamous land-deal was done. All of LTUS's 10Ks and 10Qs are signed by their Chinese CEO, not Mike, FWIW he's just a director there.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.